We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

CRIN1222 Study

Randomized, Parallel Group Study to Evaluate the Safety, Pharmacokinetics, and Dose Response of Paltusotine Treatment in Subjects with Carcinoid Syndrome

cancer cells


AGE: 18+ years old
CONDITION: Carcinoid Syndrome
TYPE: Interventional Study
LOCATION: UH Cleveland Medical Center

Learn More About This Research Study

To learn more about this study, please call study coordinator, Debbie Donohue at 216-844-4784 or complete the online form below.

Study Purpose

The purpose of this study is to learn the effects of an experimental oral medication on subjects with carcinoid syndrome. This study will help researchers understand how the medication enters the bloodstream after it is administered, how long it stays in the bloodstream, how it is absorbed, and how long it takes to be cleared from your body, and the symptomatic response of different doses of treatment in subjects with carcinoid syndrome.

Who Can Participate

Participants 18 years old and older with a diagnosis of carcinoid syndrome may be eligible for this study.

To learn more about this study, please fill out the form below to request more information.
I'm not a robot